Those who have been in IDP for a while will remember the big drop last January from 270 to 150 which was fairly terrifying. In fact I sold at a loss only to wish I hadn't a couple of months later. Won't be making the same mistake again. This company is debt free and cash generative with a proactive board keen on expansion. There are some startup costs but this company is going places IMO. It isn't AIM by the way as it's main market listed. It just behaves like AIM. Anyone care to call the bottom?
Look at the historic results RNSs Yamin and look at the SP movement. Always good/excellent results and they take it down to start with. Then it comes back higher. It's annoying but you have to hold your nerve. Or trade it if you can be bothered. Sometimes they take it down a long way..all part of the fun! I'm holding. DYOR however
I have just had a letter from Barclays telling me that from the 1st Jan IDP can no longer be traded in my SIPP. I don't have a SIPP and my IDP shares are in my ISA as a long term growth company so this is clearly a complete error on their part along with all the other change over blunders. I will ring them if I can be bothered. Anyone else had a letter?
A fire? Really? Actually this suits me as I was looking to build a bigger position, preferably in the 3s, but have been waiting on funds from elsewhere
I know this is in the hands of the p&d crew but I asked my wife who is in Pharma to look at this one. She is normally dismissive of the companies I show her but this one she said looked promising. IMO DYOR